NCT07521436 Awareness of Risk Factors and Perception of Cardiovascular Risk in Secondary Prevention Among Women and Men
| NCT ID | NCT07521436 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituti Clinici Scientifici Maugeri SpA |
| Condition | Cardiovascular Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-04-10 |
| Primary Completion | 2027-01-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2026-04-10 with a primary completion date of 2027-01-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The present research project aims to assess, through a survey, awareness of general and sex/gender-specific cardiovascular risk factors, as well as the perception of the risk of developing further cardiovascular diseases, among patients in secondary prevention.
Eligibility Criteria
Inclusion criteria: * Male or female participants aged ≥ 18 years at the time of signing informed consent. * Individuals with atherosclerotic cardiovascular disease (ASCVD), defined as at least one of the following: * Ischemic heart disease (e.g., documented myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting, or ≥50% coronary stenosis in at least two coronary territories); * Cerebrovascular disease (e.g., documented ischemic stroke; transient ischemic attack, primary intracerebral hemorrhage, and subarachnoid hemorrhage are not qualifying conditions; carotid stenting or endarterectomy); * Peripheral arterial disease (e.g., peripheral arterial intervention, stent placement, surgical revascularization, lower limb amputation due to obstructive disease, or intermittent claudication with ABI \<0.90 in the past 12 months); * Atherosclerotic aortic disease (e.g., abdominal or descending thoracic aortic aneurysm). * Signed informed consent. Exclusion Criteria: * Inability or difficulty in completing the questionnaires in Italian and/or functional illiteracy. * History of or current severe psychiatric disorder that could compromise the reliability of questionnaire responses. * Refusal or withdrawal of informed consent.
Frequently Asked Questions
Who can join the NCT07521436 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07521436 currently recruiting?
Yes, NCT07521436 is actively recruiting participants. Visit ClinicalTrials.gov or contact Istituti Clinici Scientifici Maugeri SpA to inquire about joining.
Where is the NCT07521436 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT07521436 clinical trial?
NCT07521436 is sponsored by Istituti Clinici Scientifici Maugeri SpA. The trial plans to enroll 200 participants.